NSD3 and squamous cell lung carcinoma: Although <i>EGFR</i> L858R mutation was detected throughout the transformation, genomic analyses were performed during the disease course, revealing the amplification of <i>FGFR1</i> and <i>NSD3</i>, which have recently been proposed as potential driver oncogenes in lung squamous cell carcinoma.